---
title: "Medtronic plc (MDT.US) — 公司概況"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/MDT.US/overview.md"
symbol: "MDT.US"
name: "Medtronic plc"
parent: "https://longbridge.com/zh-HK/quote/MDT.US.md"
datetime: "2026-04-05T16:22:12.908Z"
locales:
  - [en](https://longbridge.com/en/quote/MDT.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDT.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDT.US/overview.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/MDT.US/overview.md) | [简体中文](https://longbridge.com/zh-CN/quote/MDT.US/overview.md)


# Medtronic plc (MDT.US) — 公司概況

## 基本資訊

| 項目 | 詳情 |
|------|--------|
| 行業 | Health Care Equipment |
| 交易所 | US Market |
| 地址 | Building Two, Parkmore Business Park West, Galway, Co. Galway, Ireland |
| 官網 | [www.medtronic.com](https://www.medtronic.com) |

## 公司簡介

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.

## 核心管理層

| 名稱 | 職位 |
|------|-------|
| Geoffrey Straub Martha | Chairman of the Board & CEO |
| Thierry Pieton | Executive VP & CFO |
| Brett A. Wall | Executive VP & President of Neuroscience Portfolio |
| Mark Ploof | Senior Vice President of Global Operations and Business Services |
| Denise L. Blomquist | VP, Global Controller & Chief Accounting Officer |
| Elizabeth G. Nabel | Independent Director |
| Craig Arnold | Lead Independent Director |
| Gregory Peter Lewis | Independent Director |
| Kendall J. Powell | Independent Director |

## 主要股東

| 名稱 | 佔比 | 報告日期 |
|------|-------|-------------|
| The Vanguard Group, Inc. | 10.04% | 2025-12-31 |
| BlackRock, Inc. | 9.39% | 2025-12-31 |
| State Street Global Advisors, Inc. | 4.80% | 2025-12-31 |
| JP Morgan Asset Management | 3.69% | 2025-12-31 |
| Capital Research and Management Company | 3.24% | 2025-12-31 |
| Geode Capital Management, LLC | 2.17% | 2025-12-31 |
| Massachusetts Financial Services Company | 1.63% | 2025-12-31 |
| BNY Mellon Asset Management | 1.40% | 2025-12-31 |
| Deutsche Asset & Wealth Management | 1.37% | 2025-12-31 |
| Norges Bank Investment Management | 1.34% | 2025-12-31 |

## 業務構成

| 業務線 | 營收 | 佔比 |
|---------|---------|-------|
| Cardiovascular | 12481000000 | 37.12% |
| Neuroscience | 9846000000 | 29.28% |
| Medical Surgical | 8407000000 | 25% |
| Diabetes | 2755000000 | 8.19% |
| Other | 137000000 | 0.41% |
| Unallocated Other Adjustments | -90000000 | % |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Medtronic plc Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Cardiovascular",
        "ratio": 37.12
      },
      {
        "segment": "Neuroscience",
        "ratio": 29.28
      },
      {
        "segment": "Medical Surgical",
        "ratio": 25
      },
      {
        "segment": "Diabetes",
        "ratio": 8.19
      },
      {
        "segment": "Other",
        "ratio": 0.41
      },
      {
        "segment": "Unallocated Other Adjustments",
        "ratio": null
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## 地區分佈

| 地區 | 營收 | 佔比 |
|--------|---------|-------|
| United States | 17171000000 | 51.2% |
| Rest of World | 16250000000 | 48.45% |
| Ireland | 116000000 | 0.35% |


---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**